C. Huang

发表

A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin

R. Huddart, Robert J. Jones, S. Crabb, 2020, BJU international.

Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.

M. Leblanc, J. Moon, G. Wolf, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer

C. Obasaju, S. Feigenberg, B. Movsas, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I Study of Radical Thoracic Radiation, Weekly Irinotecan, and Cisplatin in Locally Advanced Non-small Cell Lung Carcinoma

M. Millenson, S. Litwin, S. Feigenberg, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Delivery of a Liposomal c-raf-1 Antisense Oligonucleotide by Weekly Bolus Dosing in Patients with Advanced Solid Tumors

C. Rudin, M. Ratain, J. Marshall, 2004, Clinical Cancer Research.

Dysgenetic hypoplastic kidney simulating metastatic lung carcinoma.

C. Huang, P. Vanveldhuizen, D. Mcgregor, 2006, Lung cancer.

Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months

Yi Cao, C. Huang, Yi Jiang, 2016, Medicine.

Chemotherapy for Small Cell Lung Cancer 58

K. Kelly, F. Shepherd, C. Huang, 2018 .

Potential Role of Platelet-Derived Growth Factor Receptor Inhibition Using Imatinib in Combination with Docetaxel in the Treatment of Recurrent Non-small Cell Lung Cancer

M. Mayo, K. Kelly, O. Tawfik, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy

M. Millenson, H. Borghaei, C. Langer, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma

Yi Cao, C. Huang, Rui-Sheng Ke, 2017, Oncology letters.

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

C. Rudin, J. Marshall, A. Dritschilo, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

K. Kelly, C. Huang, P. Neupane, 2016, Front. Oncol..

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

A. Godwin, G. Sittampalam, Sarah Schmitt, 2014, Front. Oncol..

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers

C. Huang, T. Komiya, 2018, Front. Oncol..

New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors

C. Huang, J. Treat, 2001, Oncology.